Search Results - "KAWAI, Stephen"
-
1
Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA Protein
Published in Journal of Virology (01-06-2012)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
2
Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease
Published in Journal of medicinal chemistry (13-03-2014)“…A ligand-focused strategy employed NMR, X-ray, modeling, and medicinal chemistry to expose the critical role that bioactive conformation played in the design…”
Get full text
Journal Article -
3
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV‑1
Published in ACS medicinal chemistry letters (10-04-2014)“…An assay recapitulating the 3′ processing activity of HIV-1 integrase (IN) was used to screen the Boehringer Ingelheim compound collection. Hit-to-lead and…”
Get full text
Journal Article -
4
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Published in Antimicrobial agents and chemotherapy (01-06-2014)“…BI 224436 is an HIV-1 integrase inhibitor with effective antiviral activity that acts through a mechanism that is distinct from that of integrase strand…”
Get full text
Journal Article -
5
Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly
Published in Bioorganic & medicinal chemistry letters (01-01-2011)“…The discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly is described. Synthesis of analogs of the…”
Get full text
Journal Article -
6
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Published in Nature (13-11-2003)“…Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing…”
Get full text
Journal Article -
7
Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)
Published in Journal of medicinal chemistry (09-09-2010)“…C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and…”
Get full text
Journal Article -
8
Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold
Published in Bioorganic & medicinal chemistry letters (15-12-2012)“…A uHTS campaign led to the discovery of a 5-(5-furan-2-ylpyrazol-1-yl)-1H-benzimidazole series that inhibits assembly of HIV-1 capsid. Synthetic manipulations…”
Get full text
Journal Article -
9
Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification
Published in Bioorganic & medicinal chemistry letters (01-06-2013)“…The optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly that possess a labile stereocenter at C3 is…”
Get full text
Journal Article -
10
Mobiles, Molecules and the Coalescence of Processes
Published in Leonardo (Oxford) (01-02-2013)“…The author provides an account of his development and experiences as both a visual (mobile) artist and a chemist. He describes the surprising similarities…”
Get full text
Journal Article -
11
Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure–activity relationships (SAR) of the C3-phenyl moiety
Published in Bioorganic & medicinal chemistry letters (01-06-2013)“…Detailed structure–activity relationships of the C3-phenyl moiety that allow for the optimization of antiviral potency of a series of…”
Get full text
Journal Article -
12
Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs
Published in ACS medicinal chemistry letters (11-08-2016)“…Optimization of pyridine-based noncatalytic site integrase inhibitors (NCINIs) based on compound 2 has led to the discovery of molecules capable of inhibiting…”
Get full text
Journal Article -
13
Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans
Published in Organic letters (19-08-2004)“…The synthesis of BILN 2061, an NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building…”
Get full text
Journal Article -
14
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV
Published in ACS medicinal chemistry letters (12-06-2014)“…A scaffold replacement approach was used to identifying the pyridine series of noncatalytic site integrase inhibitors. These molecules bind with higher…”
Get full text
Journal Article -
15
The Use of Chemical Double-Mutant Cycles in Biomolecular Recognition Studies: Application to HCV NS3 Protease Inhibitors
Published in ChemMedChem (17-11-2008)“…Things don′t always add up: Our understanding of biomolecular recognition processes is often complicated by the fact that the binding contributions of…”
Get full text
Journal Article -
16
The effect of the P1 side chain on the binding of optimized carboxylate and activated carbonyl inhibitors of the hepatitis C virus NS3 protease
Published in Future medicinal chemistry (01-07-2010)“…Peptidyl inhibitors of the hepatitis C virus NS3 protease hold much promise as direct-acting antiviral agents against hepatitis C infection. The optimization…”
Get more information
Journal Article -
17
Dimethylthiazolidine Carboxylic Acid as a Rigid P3 Unit in Inhibitors of Serine Proteases: Application to Two Targets
Published in Chemical biology & drug design (01-11-2009)“…Serine proteases are a very large class of enzymes, many of which represent important targets for therapeutic agents against a wide variety of disease states…”
Get full text
Journal Article -
18
Characterization of the Human Cytomegalovirus Protease As an Induced-Fit Serine Protease and the Implications to the Design of Mechanism-Based Inhibitors
Published in Journal of the American Chemical Society (07-04-1999)“…The conformational properties of the N-tert-butylacetyl-l-tert-butylglycyl-l-N δ,N δ-dimethylasparagyl-l-alanyl methyl ketone (MK) 1 and its terminal…”
Get full text
Journal Article -
19
Evidence of a Conformational Change in the Human Cytomegalovirus Protease upon Binding of Peptidyl-Activated Carbonyl Inhibitors
Published in Biochemistry (Easton) (14-10-1997)“…A series of N-tert-butylacetyl-l-tert-butylglycyl-l-N γ,N γ-dimethylasparagyl-l-alanyl-derived inhibitors (trifluoromethyl ketone 1, pentafluoroethyl ketone,…”
Get full text
Journal Article -
20
Human Cytomegalovirus Protease Complexes Its Substrate Recognition Sequences in an Extended Peptide Conformation
Published in Biochemistry (Easton) (07-07-1998)“…Substrate hydrolysis by human cytomegalovirus (HCMV) protease is essential to viral capsid assembly. The interaction of HCMV protease and the N-terminal…”
Get full text
Journal Article